Insight

Apr 8, 2024, 15:24

Amalya Sargsyan: Fantastic paper out in AACR Journals on the role of TME in NSCLC

Amalya Sargsyan, Medical Oncologist at Yeolyan Oncology and Hematology Center, shared on LinkedIn:

“Is targeting the tumor microenvironment the key to unlocking the next generation of cancer therapies?

Following the presentation at AACR2024 by Charles Swanton, this fantastic paper was out in AACR Journals on the role of TME in NSCLC.

4 TME classes in NSCLC, including a class marked by high neutrophil infiltration.
Links between TME architecture, neoantigen burden, and immune evasion spotlight the complexity of cancer evolution.
The study emphasizes the potential of targeted therapies focusing on specific TME characteristics for better outcomes.

TRACERx initiative by Cancer Research UK and The Francis Crick Institute.”

Proceed to the article.
Source: Amalya Sargsyan/LinkedIn

AACR Journals AACR24 Amalya Sargsyan American Association for Cancer Research cancer Cancer Research UK cancer therapies Charles Swanton CRUK non-small cell lung carcinoma NSCLC OncoDaily Oncology The Francis Crick Institute TRACERx initiative tumor microenvironment Yeolyan Oncology and Hematology Center

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success